Liao YS et al. |
[Anandamide inhibits the growth of colorectal cancer cells through CB1 and lipid rafts]. |
2011 |
Zhonghua Zhong Liu Za Zhi |
pmid:21575494
|
Wu WJ et al. |
[Membrane cholesterol mediates the endocannabinoids-anandamide affection on HepG2 cells]. |
2010 |
Zhonghua Gan Zang Bing Za Zhi |
pmid:20380798
|
Liu HY et al. |
[Effects of anandamide on the activation and proliferation of hepatic stellate cells through cannabinoid-2 receptors]. |
2008 |
Zhonghua Gan Zang Bing Za Zhi |
pmid:18578993
|
Waku K |
[Endogenous cannabinoid receptor ligands--anandamide and 2-arachidonoylglycerol]. |
2006 |
Yakugaku Zasshi |
pmid:16462096
|
Ueda N et al. |
Alkaline and acid amidases hydrolyzing anandamide and other N-acylethanolamines. |
2001 |
World Rev Nutr Diet |
pmid:11935959
|
Hansen HS et al. |
When and where are N-acylethanolamine phospholipids and anandamide formed? |
2001 |
World Rev Nutr Diet |
pmid:11935960
|
Roser P et al. |
Potential antipsychotic properties of central cannabinoid (CB1) receptor antagonists. |
2010 |
World J. Biol. Psychiatry |
pmid:20218784
|
Okamoto Y et al. |
Enzymatic formation of anandamide. |
2009 |
Vitam. Horm. |
pmid:19647106
|
Yates ML and Barker EL |
Organized trafficking of anandamide and related lipids. |
2009 |
Vitam. Horm. |
pmid:19647107
|
Goodfellow CE and Glass M |
Anandamide receptor signal transduction. |
2009 |
Vitam. Horm. |
pmid:19647109
|
Brown AJ and Robin Hiley C |
Is GPR55 an anandamide receptor? |
2009 |
Vitam. Horm. |
pmid:19647110
|
Correa FG et al. |
The endocannabinoid anandamide from immunomodulation to neuroprotection. Implications for multiple sclerosis. |
2009 |
Vitam. Horm. |
pmid:19647114
|
Tóth A et al. |
Anandamide and the vanilloid receptor (TRPV1). |
2009 |
Vitam. Horm. |
pmid:19647120
|
Pasquariello N et al. |
Regulation of gene transcription and keratinocyte differentiation by anandamide. |
2009 |
Vitam. Horm. |
pmid:19647122
|
Alpini G and Demorrow S |
Changes in the endocannabinoid system may give insight into new and effective treatments for cancer. |
2009 |
Vitam. Horm. |
pmid:19647123
|
Glaser ST et al. |
Endocannabinoids in the intact retina: 3 H-anandamide uptake, fatty acid amide hydrolase immunoreactivity and hydrolysis of anandamide. |
2005 Nov-Dec |
Vis. Neurosci. |
pmid:16469181
|
Cruz F |
Mechanisms involved in new therapies for overactive bladder. |
2004 |
Urology |
pmid:15013655
|
Devane WA |
New dawn of cannabinoid pharmacology. |
1994 |
Trends Pharmacol. Sci. |
pmid:8165721
|
Fowler CJ |
Anandamide uptake explained? |
2012 |
Trends Pharmacol. Sci. |
pmid:22297258
|
Zygmunt PM et al. |
Anandamide - the other side of the coin. |
2000 |
Trends Pharmacol. Sci. |
pmid:10664604
|
Di Marzo V and Maccarrone M |
FAAH and anandamide: is 2-AG really the odd one out? |
2008 |
Trends Pharmacol. Sci. |
pmid:18394720
|
Smart D and Jerman JC |
Anandamide: an endogenous activator of the vanilloid receptor. |
2000 |
Trends Pharmacol. Sci. |
pmid:10740287
|
Szolcsányi J |
Anandamide and the question of its functional role for activation of capsaicin receptors. |
2000 |
Trends Pharmacol. Sci. |
pmid:10838604
|
Piomelli D et al. |
The endocannabinoid system as a target for therapeutic drugs. |
2000 |
Trends Pharmacol. Sci. |
pmid:10838609
|
Fowler CJ |
Has FLAT fallen flat? |
2014 |
Trends Pharmacol. Sci. |
pmid:24398120
|
Randall MD and Kendall DA |
Endocannabinoids: a new class of vasoactive substances. |
1998 |
Trends Pharmacol. Sci. |
pmid:9550942
|
Gunduz-Cinar O et al. |
Amygdala FAAH and anandamide: mediating protection and recovery from stress. |
2013 |
Trends Pharmacol. Sci. |
pmid:24325918
|
Di Marzo V et al. |
Anandamide: some like it hot. |
2001 |
Trends Pharmacol. Sci. |
pmid:11431028
|
Szallasi A and Di Marzo V |
New perspectives on enigmatic vanilloid receptors. |
2000 |
Trends Neurosci. |
pmid:11006466
|
Alhouayek M and Muccioli GG |
The endocannabinoid system in inflammatory bowel diseases: from pathophysiology to therapeutic opportunity. |
2012 |
Trends Mol Med |
pmid:22917662
|
Gaetani S et al. |
Anandamide hydrolysis: a new target for anti-anxiety drugs? |
2003 |
Trends Mol Med |
pmid:14604824
|
Maccarrone M |
Inhibition of anandamide hydrolysis: cells also know how to do it. |
2004 |
Trends Mol Med |
pmid:14720580
|
Mechoulam R et al. |
Cannabinoids and brain injury: therapeutic implications. |
2002 |
Trends Mol Med |
pmid:11815270
|
Maccarrone M et al. |
Intracellular trafficking of anandamide: new concepts for signaling. |
2010 |
Trends Biochem. Sci. |
pmid:20570522
|
Bluett RJ et al. |
Central anandamide deficiency predicts stress-induced anxiety: behavioral reversal through endocannabinoid augmentation. |
2014 |
Transl Psychiatry |
pmid:25004388
|
Leweke FM et al. |
Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia. |
2012 |
Transl Psychiatry |
pmid:22832859
|
Hsu SS et al. |
Anandamide-induced Ca2+ elevation leading to p38 MAPK phosphorylation and subsequent cell death via apoptosis in human osteosarcoma cells. |
2007 |
Toxicology |
pmid:17222495
|
Carr RL et al. |
Effect of developmental chlorpyrifos exposure, on endocannabinoid metabolizing enzymes, in the brain of juvenile rats. |
2011 |
Toxicol. Sci. |
pmid:21507991
|
Carr RL et al. |
Induction of endocannabinoid levels in juvenile rat brain following developmental chlorpyrifos exposure. |
2013 |
Toxicol. Sci. |
pmid:23761300
|
Kodani SD et al. |
Parabens inhibit fatty acid amide hydrolase: A potential role in paraben-enhanced 3T3-L1 adipocyte differentiation. |
2016 |
Toxicol. Lett. |
pmid:27659731
|
Kaplan BL et al. |
Inhibition of leukocyte function and interleukin-2 gene expression by 2-methylarachidonyl-(2'-fluoroethyl)amide, a stable congener of the endogenous cannabinoid receptor ligand anandamide. |
2005 |
Toxicol. Appl. Pharmacol. |
pmid:15893538
|
Kondakala S et al. |
Effects of acute exposure to chlorpyrifos on cholinergic and non-cholinergic targets in normal and high-fat fed male C57BL/6J mice. |
2017 |
Toxicol. Appl. Pharmacol. |
pmid:29097212
|
Quistad GB et al. |
Fatty acid amide hydrolase inhibition by neurotoxic organophosphorus pesticides. |
2001 |
Toxicol. Appl. Pharmacol. |
pmid:11350214
|
Vilela LR et al. |
Enhancement of endocannabinoid signaling protects against cocaine-induced neurotoxicity. |
2015 |
Toxicol. Appl. Pharmacol. |
pmid:25933444
|
Matsuda K et al. |
The cannabinoid 1 receptor antagonist, AM251, prolongs the survival of rats with severe acute pancreatitis. |
2005 |
Tohoku J. Exp. Med. |
pmid:16141678
|
Descalzi F et al. |
Platelet-rich plasma exerts antinociceptive activity by a peripheral endocannabinoid-related mechanism. |
2013 |
Tissue Eng Part A |
pmid:23578218
|
Okamoto H et al. |
Sphingosine 1-phosphate stimulates G(i)- and Rho-mediated vascular endothelial cell spreading and migration. |
2000 |
Thromb. Res. |
pmid:10942792
|
Maccarrone M |
The blissful state of endothelium. |
2003 |
Thromb. Haemost. |
pmid:12719771
|
Yamaji K et al. |
Anandamide induces apoptosis in human endothelial cells: its regulation system and clinical implications. |
2003 |
Thromb. Haemost. |
pmid:12719786
|
Maccarrone M et al. |
Regulation by cannabinoid receptors of anandamide transport across the blood-brain barrier and through other endothelial cells. |
2006 |
Thromb. Haemost. |
pmid:16543970
|